Ayurvedic management of Napkin rashes

Evaluatation of the efficacy of kailas jeevan in the managemnt of diaper dermatitis in children -an open clinical study

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/03/031869

Enrollment

Registered

2021-03-10

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L22- Diaper dermatitis

Interventions

Intervention1: Kailash Jeevan ointment will be applied externally: On the diagnosed cases of diaper Dermatitis KAilash jeevan will be applied externally for a period of 10 days or untill recovery whic

Eligibility

Inclusion criteria

Inclusion criteria: Neonates, Infants and Toddlers from birth to 3 years suffering from signs and symptoms of Diaper Dermatitis.

Exclusion criteria

Exclusion criteria: Children under the medication for systemic and topical diseases. Children with with severe infective Diaper Dermatitis needing emergency medications Children with acute or chronic illnesses that necessitates exclusion will be excluded

Design outcomes

Primary

Measure	Time frame
At the end of the treatment period the subjects will have improvement in signs and symptoms of Diaper dermatitisTimepoint: 18 months	—

Secondary

Measure	Time frame
There will be no intended secondary outcomeTimepoint: 18 months	—

Countries

India

Contacts

Public ContactDr Azizahmed Arbar

KAHER KLE SBMK Ayurveda Mahavidyalaya

azizarbar.kaher@kleayurworld.edu.in9844532113

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026